Endothelin antagonists and pulmonary hypertension

被引：0

作者：

Simonsen, U. ^{[1
]}

机构：

[1] Univ Aarhus, Dept Pharmacol, Aarhus, Denmark

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2004年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：18 / 18

页数：1

共 50 条

[21] Endothelin and endothelin antagonists in hypertension
Schiffrin, EL
JOURNAL OF HYPERTENSION, 1998, 16 (12) : 1891 - 1895
[22] Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension
Ghofrani, H. A.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S177 - S178
[23] Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension
Montani, D.
Humbert, M.
REVUE DES MALADIES RESPIRATOIRES, 2010, 27 (02) : 103 - 105
[24] Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008
Cacoub, P.
Amoura, Z.
Langleben, D.
REVUE DE MEDECINE INTERNE, 2008, 29 (04): : 283 - 289
[25] Role of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension
Abman, Steven H.
ANNUAL REVIEW OF MEDICINE, 2009, 60 : 13 - 23
[26] BENEFICIAL EFFECTS OF ENDOTHELIN RECEPTOR ANTAGONISTS ON SECONDARY PULMONARY HYPERTENSION
Michalopoulou, H.
Michaloliakou, M.
Vaitsis, J.
Stamatis, D.
Stamatis, P.
JOURNAL OF HYPERTENSION, 2009, 27 : S206 - S206
[27] Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension?
Franco-Cereceda, A
Holm, P
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S447 - S452
[28] Comparative Safety and Tolerability of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
Meghan Aversa
Sandra Porter
John Granton
Drug Safety, 2015, 38 : 419 - 435
[29] Comparative Safety and Tolerability of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
Aversa, Meghan
Porter, Sandra
Granton, John
DRUG SAFETY, 2015, 38 (05) : 419 - 435
[30] Endothelin receptor antagonists for pulmonary arterial hypertension - Rationale and place in therapy
Price, Laura C.
Howard, Luke S. G. E.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (03) : 171 - 185

← 1 2 3 4 5 →